Im S - Search Results

1

Ribociclib plus fulvestrant for postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in the phase III randomized MONALEESA-3 trial: updated overall survival.

Slamon DJ, Neven P, Chia S, Jerusalem G, De Laurentiis M, Im S, Petrakova K, Valeria Bianchi G, Martín M, Nusch A, Sonke GS, De la Cruz-Merino L, Beck JT, Ji Y, Wang C, Deore U, Chakravartty A, Zarate JP, Taran T, Fasching PA. Slamon DJ, et al. Among authors: im s. Ann Oncol. 2021 Aug;32(8):1015-1024. doi: 10.1016/j.annonc.2021.05.353. Epub 2021 Jun 5. Ann Oncol. 2021. PMID: 34102253 Free article. Clinical Trial.

2

A phase II trial of S-1 and cisplatin in patients with metastatic or relapsed biliary tract cancer.

Kim YJ, Im SA, Kim HG, Oh SY, Lee KW, Choi IS, Oh DY, Lee SH, Kim JH, Kim DW, Kim TY, Kim SW, Heo DS, Yoon YB, Bang YJ. Kim YJ, et al. Among authors: im sa. Ann Oncol. 2008 Jan;19(1):99-103. doi: 10.1093/annonc/mdm439. Epub 2007 Sep 9. Ann Oncol. 2008. PMID: 17846018 Free article. Clinical Trial.

3

Effective second-line chemotherapy for extranodal NK/T-cell lymphoma consisting of etoposide, ifosfamide, methotrexate, and prednisolone.

Kim BS, Kim DW, Im SA, Kim CW, Kim TY, Yoon SS, Heo DS, Bang YJ, Park S, Kim BK, Kim NK. Kim BS, et al. Among authors: im sa. Ann Oncol. 2009 Jan;20(1):121-8. doi: 10.1093/annonc/mdn551. Epub 2008 Aug 5. Ann Oncol. 2009. PMID: 18684695 Free article. Clinical Trial.

4

Age and HER2 expression status affect MRI accuracy in predicting residual tumor extent after neo-adjuvant systemic treatment.

Moon HG, Han W, Lee JW, Ko E, Kim EK, Yu JH, Kang SY, Moon WK, Cho N, Park IA, Oh DY, Han SW, Im SA, Noh DY. Moon HG, et al. Among authors: im sa. Ann Oncol. 2009 Apr;20(4):636-41. doi: 10.1093/annonc/mdn683. Epub 2009 Jan 29. Ann Oncol. 2009. PMID: 19179551 Free article.

5

Biomarker analysis in stage III-IV (M0) gastric cancer patients who received curative surgery followed by adjuvant 5-fluorouracil and cisplatin chemotherapy: epidermal growth factor receptor (EGFR) associated with favourable survival.

Kim JS, Kim MA, Kim TM, Lee SH, Kim DW, Im SA, Kim TY, Kim WH, Yang HK, Heo DS, Bang YJ, Lee KU, Choe KJ, Kim NK. Kim JS, et al. Among authors: im sa. Br J Cancer. 2009 Mar 10;100(5):732-8. doi: 10.1038/sj.bjc.6604936. Br J Cancer. 2009. PMID: 19259093 Free PMC article.

6

Combination chemotherapy with capecitabine and cisplatin for patients with metastatic hepatocellular carcinoma.

Lee JO, Lee KW, Oh DY, Kim JH, Im SA, Kim TY, Bang YJ. Lee JO, et al. Among authors: im sa. Ann Oncol. 2009 Aug;20(8):1402-7. doi: 10.1093/annonc/mdp010. Epub 2009 Jun 5. Ann Oncol. 2009. PMID: 19502532 Free article.

7

Multicentre phase II trial of bevacizumab combined with docetaxel-carboplatin for the neoadjuvant treatment of triple-negative breast cancer (KCSG BR-0905).

Kim HR, Jung KH, Im SA, Im YH, Kang SY, Park KH, Lee S, Kim SB, Lee KH, Ahn JS, Kim SI, Sohn JH. Kim HR, et al. Among authors: im yh, im sa. Ann Oncol. 2013 Jun;24(6):1485-90. doi: 10.1093/annonc/mds658. Epub 2013 Feb 4. Ann Oncol. 2013. PMID: 23380385 Free article. Clinical Trial.

8

Cortés J, Baselga J, Im YH, Im SA, Pivot X, Ross G, Clark E, Knott A, Swain SM. Cortés J, et al. Among authors: im yh, im sa. Ann Oncol. 2013 Oct;24(10):2630-2635. doi: 10.1093/annonc/mdt274. Epub 2013 Jul 17. Ann Oncol. 2013. PMID: 23868905 Free article. Clinical Trial.

9

Palbociclib in Hormone-Receptor-Positive Advanced Breast Cancer.

Turner NC, Ro J, André F, Loi S, Verma S, Iwata H, Harbeck N, Loibl S, Huang Bartlett C, Zhang K, Giorgetti C, Randolph S, Koehler M, Cristofanilli M; PALOMA3 Study Group. Turner NC, et al. N Engl J Med. 2015 Jul 16;373(3):209-19. doi: 10.1056/NEJMoa1505270. Epub 2015 Jun 1. N Engl J Med. 2015. PMID: 26030518 Free article. Clinical Trial.

10

Quantitative proteomic analysis of HER2 expression in the selection of gastric cancer patients for trastuzumab treatment.

An E, Ock CY, Kim TY, Lee KH, Han SW, Im SA, Kim TY, Liao WL, Cecchi F, Blackler A, Thyparambil S, Kim WH, Burrows J, Hembrough T, Catenacci DVT, Oh DY, Bang YJ. An E, et al. Among authors: im sa. Ann Oncol. 2017 Jan 1;28(1):110-115. doi: 10.1093/annonc/mdw442. Ann Oncol. 2017. PMID: 27687309 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,535 results

Search Page